NCT00615498

Brief Summary

Current research shows that obesity greatly increases the risk of developing asthma. Although the two conditions are clearly related, experts do not fully understand why they are linked. Some researchers believe that hormones released in the fat cells (adipokines) play a role. Others believe that excess weight pressing on the lungs triggers the hyperreactive response in the airways that is typical of asthma. The goal of the Asthma-Bariatric Surgery Study is to determine how weight loss affects lung function and various biological parameters. Bariatric (weight loss) surgery refers to the various surgical procedures performed to treat obesity. Specifically, this study is designed to answer the following questions:

  • Does bariatric surgery help patients control their asthma?
  • How much asthma control can be achieved through weight loss?
  • How does weight loss influence lung function? Participants in this observational research study will be asked to complete study visits at enrollment, 1 month, 6 months, and 12 months. Questionnaires, pulmonary function tests, and blood samples will be required at each time point. This research study is observational only; it does not cover the cost of (or provide) bariatric surgery. Optional genetic and bronchoscopy substudies are included as well.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2006

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2006

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

February 4, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 14, 2008

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
Last Updated

July 31, 2013

Status Verified

July 1, 2013

Enrollment Period

2.2 years

First QC Date

February 4, 2008

Last Update Submit

July 30, 2013

Conditions

Keywords

Asthma, obesity, bariatric

Outcome Measures

Primary Outcomes (2)

  • To measure levels of exhaled nitric oxide, reactive nitrogen species, exhaled biomarkers of lipid peroxidation, asthma quality of life, airway function (spirometry and response to methacholine), and degree of asthma control

    Enrollment, 1 month, 6 months, and 1 year

  • To measure systemic markers of redox stress and inflammation, including plasma levels of adipokines, adiposity-related cytokines (IL-6, TNF-α), GSH/GSSG, 8-isoprostanes, and leukotrienes

    Enrollment, 1 month, 6 months, and 1 year

Study Arms (2)

Surgical cases

Subjects who are undergoing bariatric surgery

Controls

Subjects who qualify for bariatric surgery but do not undergo the procedure

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Obese asthmatics

You may qualify if:

  • Non-smoker, or a limited smoking history
  • Meet criteria for bariatric surgery according to NIH guidelines

You may not qualify if:

  • Illicit drug use
  • Greater than 10 pack-year history of cigarette smoking
  • Other significant lung pathology
  • Other significant non-pulmonary co-morbidities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University, Emory Crawford Long Hospital, Clinical Research Center

Atlanta, Georgia, 30308, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood and exhaled breath condensate samples will obtained at all time points (baseline, 1 month, 6 months, and 1 year.

MeSH Terms

Conditions

AsthmaObesity

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 4, 2008

First Posted

February 14, 2008

Study Start

July 1, 2006

Primary Completion

September 1, 2008

Study Completion

September 1, 2008

Last Updated

July 31, 2013

Record last verified: 2013-07

Locations